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It has been demonstrated that  a  single intradermal  injection of cell wall 
fragments  of  Group  A  streptococci into  rabbit  skin  will  initiate  a  chronic 
granulomatous lesion characterized by remissions and exacerbations (1-3). A 
basic feature of the pathogenesis of this  experimental lesion is the  relation- 
ship between lesion activity and the ability of the host to eliminate the cell 
wall material  from the  tissue  (4).  Although  the  evidence accumulated  thus 
far  indicates  that  direct  toxicity of  the  persisting  cell  wall  structure  is  of 
primary importance (5,  6),  we  are  continuing to investigate the role of the 
immune response of the host in our studies of the mechanism of this lesion. 
More recently this experimental model of tissue damage has been extended 
to the rabbit joint (7)  and the mouse heart (8). The available data indicate 
that all of these models involve a common pathogenic mechanism. This paper 
extends the histological description of the cardiac lesions produced with crude 
extract  and  demonstrates  that  these  lesions  can  be  produced  with  isolated 
ceU wall  fragments.  Employing fluorescein or 12SI-labeled antibodies  specific 
for Group A  streptococcal cell wall antigens,  it is  readily demonstrable that 
cell wall material accumulates in the mediastinal lymph nodes and  adjacent 
loose connective tissue and can persist at these sites for at least 10 wk.  Fur- 
thermore, the cell wall fragments are shown to be localized around the sites of 
active lesions in the heart. 
Materials and Methods 
Animals.--An outbred line of Swiss-Webster white mice (Blue Spruce Farm, Altamont, 
N. Y.)and an inbred Call strain were used. All animals were male. 
Bavtvrial Fractions.--Further details have been presented previously (2). Group A, Type 
3, strain D-58 streptococci  were cultured for 16 hr in 30 liters of trypticase-soy broth. The 
cells were collected in a Servall continuous flow rotor, washed three times with 1 liter of 
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cold saline and resuspended to approximately a 300-fold concentration in pH 7.0 •/15  phos- 
phate-buffered saline (PBS). These suspensions were then disrupted in 30 ml aliquots with 
30 g of No. 12 glass beads in a Braun MSK shaker with flowing CO2, using 3 rain treatments. 
The glass beads were allowed to settle and the superuatant removed. The beads were rinsed 
several times and the rinses pooled with the first superuatant. 
Cell Walls.--The suspension of disrupted cells was diluted  to approximately 800 ml to 
reduce viscosity, and centrifuged at 10,000 g in a Servall SS-34 rotor for 30 rain. The top layer 
of  sediment was  carefully resuspended  in buffered  saline and  this cycle  of centrifugation 
was repeated three times. The final suspension was treated with ribonuclease, trypsin, and 
Duponol as previously described  (2). The Duponol was removed by washing the cell walls 
five times with water at 25°C.  The cell walls were then dialyzed against distilled water and 
lyophilized. For injection,  100 mg was suspended in  15 ml of PBS and sonicated within a 
glass vial for 2 rain in the cup of a 9KC Raytheon sonic oscillator, which contained 5 ml of 
water. 
Cell Wall  Fragments.--lO0 mg of  the cell wall preparation was  suspended  in  15  ml of 
PBS and treated for 75 rain at maximum amplitude in the cup of the Raytheon 9 KC sonic 
oscillator.  This yielded  an opalescent  stable suspension.  This preparation was  very poly- 
disperse, and the range of particle size has not been determined. With comparable prepara- 
tions it has been demonstrated that most of the toxicity, as defined by nodular lesions in rab- 
bit skin, is sedimented at 90,000 g but not 27,000 g. 
Soluble Fraction of Streptococcal Cdls.--The first supernatant obtained after centrifuga- 
tion of the crude extract at 10,000 g was further centrifuged twice at 37,000 g for 1 hr in a 
Servall SS-34 rotor. The supernatant was dialyzed against deionized water at 4°C and lyoph- 
ilized.  This  contains  the  soluble  cytoplasmic  components  and only trace amounts of cell 
wall can be detected by rhamnose determinations and immunodiffusion. This will, of course, 
depend a  great deal upon the degree of solubilization of the cell wall during the disruption 
of the cells.  For injection, 100 mg was suspended in 15 ml of PBS and a  clear solution ob- 
tained by sonication for 2 min as described for the cell wall material. 
Crude Sonic Extraas.--Washed cells from either Group A or Group D  streptococcal broth 
cultures were resuspended in PBS and disrupted with a Bronson sonifier, without glass beads, 
employing 60 mill treatment. The crude extract was filtered through Millipore 3  /~,  1.2 #, 
and 0.45 #  filters in succession. After the last filtration, a  portion of the filtrate was tested 
for sterility by plating on a  sheep blood agar plate. Rhamnose determinations were done on 
each lot of sonicate as an estimate of the cell wall material present and/or a method of stand- 
ardization of dosage. 
Preparation for Injection of Mice.--For experiments comparing cell wall and soluble frac- 
tions each preparation was diluted to 20 ml with pH 7.0 PBS and held at 62°C for 30 min 
prior  to injection.  Sterility was  checked  by  plating  0.1  ml samples  on  sheep  blood agar 
plates. 
Preparatlen of Tissue for Histological Exarainalien.--Tissues  were fixed in  10%  neutral 
formalin  and  the paxaffm-embedded sections were  stained with hematoxyiin and eosin  or 
Giemsa. 
Identification of Group A  Streptococcal Cell Wall Antigens in Tissue.--The preparation  of 
antibodies specific for the polysaecharide or mucopeptide cell wall antigens, their labeling 
with fluorescein isothiocyanate or 125I, and the fluorescence microscopy or  radioantography 
techniques have been described in detail (4, 9). 
The tissues from all Swiss-Webster mice, injected intraperitoneally or intravenously with 
crude sonic extract, were fixed in formalin,  paraffin--embedded, and sections 4/z  thick pre- 
pared. These could only be studied  by  radioautography with the radioantibodies because of 
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Tissues from the  Call strain  of mice, injected with isolated cell wall fragments, were 
fixed in cold ethanol and processed by the method of Sainte-Marie (10). These tissues were 
examined both by fluoresceindabeled  and 12sI-labeled antibodies. 
Controls consisted of tissues stained with normal labeled globulin or blocking with un- 
labeled antibody prior to the  application of labeled antibody.  Other controls consisted of 
tissue from mice injected with buffered saline or with Group D streptococcus cell wall prepa- 
rations. The latter is an important  control for nonspecitic sticking of globulin in areas of 
inflammation. 
RESULTS 
Production  of Cardiac  Lesions  witk Cell  Wall Fragments.  m 
Swiss-Webster mice weighing 24-28 g were divided into four groups of 10 mice. Each group 
was injected intraperitoneally with one of the following preparations: (a) 10 mg of Group A 
streptococcal cell walls sonicated for 2 rain to give an even suspension, (b) 10 mg of fragments 
of the same cell wall preparation produced by sonication for 75 rain, (¢) 10 mg of the soluble, 
cytoplasmic fraction of the cells, (d) 2 ml of the phosphate-buffered saline, pH 7.0, in which 
the above preparations were suspended. Two mice from each group were killed at weekly 
intervals for 5 wk after injection and the tissues prepared for histological examination. 
All mice injected with the cell wall fragments developed a carditis with the 
essential  features  described  previously  (8),  although  the  lesions  are  not  as 
extensive. None of the mice injected  with  the  other preparations,  including 
nonfragmented  cell walls,  showed heart  lesions.  These  results  are  tabulated 
in Table I.  The histopathology in  these  animals was compared with lesions 
produced with crude extract containing a similar amount of cell wall material 
(3.5 mg of thamuose). The characteristic features are summarized as follows: 
The carditis was characterized by involvement of the pericardium, myocardium, 
coronary arteries,  and the heart valves. The lesions of the  pericardium con- 
sisted of focal collections of mononuclear ceils and neutrophils on the epicardial 
surface and infiltration of the subepicardial tissue by similar cells. The myo- 
cardial lesions were characterized by areas of necrosis which were surrounded 
by  a  variety  of  cells  including  mononucleax  and  giant  cells  with  irregular 
basophilic cytoplasm, indistinct cell borders, and nuclei typical of Anitschkow's 
myocytes.  These  lesions  were  most  numerous  in  the  wall  of the  left ven- 
tricle,  intraventricular  septum,  and  papillary  muscles  of the  left  ventricle. 
Many of the focal myocardial lesions were located adjacent to coronary arteries 
and some appeared to surround arteries (Figs. 1 and 2). Changes in the coronary 
arteries  were  observed  throughout  the  experiments.  The  type  of lesion  ob- 
served most commonly is illustrated in Fig. 3. Changes consisted of endothelial 
hyperplasia, edema of the media,  and accumulations of mononuclear cells in 
the media and adventitia. Arterial necrosis and thrombosis were not observed. 
The  cusps  and bases  of the  aortic  and mitral valves were involved by the 
inflammatory process. There was edema of the interstitial tissue with accumula- 
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The roots  of the mitral and aortic valves and adjacent myocardium showed 
areas of necrosis and accumulations  of a variety of inflammatory cells similar 
to those seen in the focal  lesions of the myocardium described  above.  The 
endocardium  adjacent to the valves showed hyperplasia and infiltration with 
inflammatory cells. In  addition to  the  diffuse inflammatory process  of the 
valves, nodular lesions were observed in which the endocardium was elevated by 
dense  focal  accumulations  of inflammatory cells. Inflammation of  a  mitral 
valve is illustrated in Fig. 4. 
Localization  of Cell Wall Antigens in Relation  to Cardiac Lesions.--As  de- 
scribed above, the lesion process in mice injected with either crude extract of 
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sonic  disrupted  Group  A  streptococci  or  isolated  cell  wall  fragments was 
essentially  similar.  Likewise,  the  distribution  and  persistence  of  cell wall 
antigens were comparable. 
A  total of 25 mice from a  series involving the intravenous or intraperitoneal injection of 
Swiss-Webster animals with the crude sonic extract, and 14 mice from a  group of Call ani- 
mah injected intraperitoneMly with isolated  Group A  cell wall fragments, were examined 
for localization of cell wall antigens. Animals were kiLled at intervals from 1 day to  10 wk 
after injection of either Group A streptococcal cell wall fragments or crude extract, Group D 
streptococcal cell wail fragments or crude extract, or buffered saline. Usually two or three 
animals from each group were studied at the selected time intervals. Tissue sections were 
examined by fluorescence microscopy or radioautography using labeled antibodies specific 
for Group A polysaccharide, or mucopeptide. The controls used are described under Materials 
and Methods. 
Cell wall antigens  could be readily demonstrated in the spleen, liver,  and 
mediastinal lymph nodes  in samples  obtained at every interval from 24  hr 
to 10 wk. The localization of antigen in the lung was more variable as judged 
by  intensity of  silver  grains,  while  antigen was  seen  only occasionally  in 
glomemli of the kidney and not in the thymus. 
Antigen was detected at 2-4 days in the pericardium,  with some variability 
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wk;  Cell  wall  antigen  was  also observed, with  individual  variation,  in  the 
myocardium, atrium, and mitral valve. 
With regard to the relationship of cell wall material to the histopathology, 
we have concluded that an active lesion process is associated with the presence 
of antigen.  With the greater precision  of the fluorescent antibody technique, 
the  antigens  were  always observed at  the  periphery  of the  sites  of granu- 
lomatous inflammation,  as illustrated in Figs. 5-8. On the other hand, antigen 
was frequently found in the heart in the absence of any obvious tissue damage 
(Figs.  9-12). 
It is interesting  that  antigen  was always found in the mediastinal  lymph 
nodes and appeared as a continuum through the loose connective tissue around 
the blood vessels in this area. Fig. 13 illustrates the intensity of the fluorescence 
in  the mediastinal  node  8  days after injection.  The  intensity  of the  radio- 
autograph of the loose connective tissue 10 wk after injection is recorded in 
Fig. 14. 
DISCUSSION 
The lesions produced in the hearts of mice injected with Group A strepto- 
coccal cell wall fragments are strikingly similar  to the cardiac lesions of rheu- 
matic fever. The studies reported here indicate that the active lesion process is 
associated with  the  localization  of the  cell  wall material  around  the  site of 
tissue damage. Other studies conducted in rabbit skin have demonstrated the 
toxicity of Group A streptococcal cell walls,  probably functioning through  a 
direct toxic activity of the mucopeptide moiety (11). The mechanism by which 
the cardiac lesion  could develop as a  result of deposition of cell walls is not 
known.  It  could  conceivably  involve  hypersensitivity  or  an  autoimmune 
reaction. Although our studies with this material in the other tissue models do 
not support  this  concept,  we are pursuing  the  possibility that  the  immune 
response of the host is directly involved in the pathological events. Serological 
studies show that mice injected with the dose of cell walls employed here do 
develop cell wall agglutinating  antibodies 4--7 days after injection,  and then 
maintain  a  rather  constant  level of circulating  antibody for  at  least 24  wk 
(12). 
It was noted that cell wall antigen was found only at the periphery of the 
sites of granulomatous inflammation,  and was frequently seen in the heart in 
the absence of obvious lesion activity. This suggests that the lesions  develop 
in the process of the host's efforts to eliminate  cell wall material,  whatever 
mechanisms  this  may involve.  Thus,  cell  wall is  not  detected in  advanced 
lesion processes,  and those apparently normal sites where it is found represent 
areas of potential lesion development. Since the mice are producing antibody, 
the inability to detect cell walls within an active lesion could be the result of 
blocking of antigenic sites by the host's antibody. We have not,  as yet, been 42  GROUP A  STREPTOCOCCAL  CELL WALL  IN HEART 
able to demonstrate mouse immunoglobulins in the lesions. This critical question 
must be  resolved by complementing our studies with internally labeled cell 
walls.  The bound globulin,  which Kaplan et al.  (13)  have demonstrated in 
hearts from patients dying of acute rheumatic fever, could be interpreted as 
antibody against localized Group A  streptococcal  cell  wall  antigens,  rather 
than the autoantibodies reacting with myofiber sarcolemma which these workers 
postulate. The fact that the bound globulin in human hearts is not  found in 
the  Aschoff lesion  but  is  associated  with  uninvolved tissue  (13)  would,  in 
fact, fit with our observations. 
The relative ineffectiveness of the large  cell  wall suspension compared  to 
cell wall fragments is similar to the previous observation on an optimum par- 
ticle size  for development of nodular skin lesions (14).  This may reflect the 
distribution and localization at  a  critical site,  or differential processing  and 
elimination of different size particles. 
The accumulation and persistence of cell  wall material in the mediastinal 
lymph nodes is remarkable, and the possibility that lymphoid tissue represents 
the mode of translocation of Group A  streptococcal cell walls to the  heart is 
being investigated. 
SUMMARY 
Mice injected intraperitoneally with isolated cell wall fragments of Group 
A streptococci develop a  carditis similar to that previously observed in mice 
injected with crude extracts of this organism. Neither the soluble cytoplasmic 
components of Group A streptococcal cells  nor the  nonfragmented cell walls 
produced  carditis  in  this  experimental  model.  Fluorescein  and  USLlabeled 
antibodies specific  for Group A  streptococcal cell wall antigens were used to 
demonstrate that, for 5 wk after injection, cell wall material is localized around 
the sites of active lesions in the heart. In addition, the cell wall antigen ac- 
cumulates in the liver, spleen, mediastinal lymph nodes, and the adjacent loose 
connective tissue, where it persists for at least 10 wk. 
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FIo. 1.  Myofiber necrosis and accumulation of mononuclear cells. Section from a 
mouse sacrificed 2 wk after injection of crude extract of Group A streptococcal cells. 
×  513. 
FIG. 2.  Granuloma adjacent to a coronary artery. Section from a mouse sacrificed 
3 wk after injection of crude extract of Group A streptococcal cells.  >(  102. 
FIG. 3.  Arteritis of a  coronary artery. Section from a mouse sacrificed  1 wk after 
injection of crude extract Group A streptococcal cells.  ×  513. 
FIG. 4. Inflammation of the mitral valve. Section from a  mouse sacrificed  3 wk 
after injection of crude extract of Group A streptococcal cells.  ×  102. 45 46  GROUP  A  STREPTOCOCCAL CELL  WALL IN  HEART 
FIG.  5.  Granulomatous  lesion  around  coronary  artery  in  a  C3H  mouse  injected 
intraperitoneally  2  wk  previously  with  Group  A  streptococcal  cell  wall  fragments. 
Giemsa stain.  X  82. 
FIG. 6.  Higher magnification of left middle area of Fig. 5.  X  342. 
FIG.  7.  Same section shown in Fig. 6,  stained with fluorescein-labeled anti-Group 
A  polysaccharide.  Fluorescence  can  be  identified  with  specific  mononuclear  cells. 
30 sec exposure.  X  342. 
FIG. 8.  Serial section of heart  shown in Figs. 5-7.  Stained with fluorescein-labeled 
normal rabbit globulin. 40 sec exposure.  X  342. 47 48  GROUP  A  STREPTOCOCCAL CELL  WALL IN  HEART 
FIG.  9.  Heart  taken  from mouse injected 2  wk previously with  Group  A  strepto- 
coccal cell wall fragments. Minimal inflammation in valve and adjacent tissue. Giemsa 
stain.  X  73. 
FIG. 10.  Serial section of heart shown in Fig. 9. Approximately same area as shown 
in Figs. 11  and  12.  Control showing absence of fluorescence when stained with fluores- 
celn-labeled anti-Group  D  polysaecharide.  90  sec exposure.  X  308. 
FIG. 11.  Higher magnification of right middle area of Fig. 9.  X  308. 
Fro.  12.  Same section shown in Fig. 11, stained with fluorescein-labeled anti-Group 
A  polysaccharide.  Fluorescence can  be  identified  with  specific cells seen  in  Fig.  11. 
40 sec exposure.  X  508. 
FIG.  13.  Lymph node  adjacent  to heart in  Call mouse injected 8  days previously 
with  Group  A  cell  wall  fragments.  Stained  with  fluorescein-labeled  anti  Group  A 
polysaccharide. 30 sec exposure.  X  73. 
Fro.  14.  Loose connective tissue around  large vessels in mediastinum.  Call mouse 
injected intraperitoneally  10 wk previously with Group A cell wall fragments.  Radio- 
autograph  of  section  stained  with  12~I anti  Group  A  polysaccharide  followed  by 
Giemsa stain after photographic development.  X  73. 49 